Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Volatile Compounds in Musk and Their Anti-Stroke Mechanisms.
Chengli Zheng1, Xin Shi1, Qinling Yang2
1Sichuan Institute of Musk Deer Breeding, Sichuan Institute for Drug Control, Chengdu 611845, China.
This study analyzed volatile compounds (VCs) in musk, finding key differences that impact stroke treatment. These VCs show potential for developing new stroke therapies.
Area of Science:
- Pharmacology
- Traditional Chinese Medicine
- Analytical Chemistry
Background:
- Musk, a traditional Chinese medicine, is used for its blood-activating and resuscitation properties.
- Volatile compounds (VCs) in musk are crucial for its therapeutic effects, particularly in stroke treatment.
- Comprehensive analysis of VCs in different musk types is lacking.
Purpose of the Study:
- To investigate the differences in volatile compounds (VCs) across various musk types.
- To identify potential therapeutic targets and mechanisms of musk VCs for stroke treatment.
- To explore the pharmacological basis of musk's efficacy in traditional medicine.
Main Methods:
- Gas chromatography-mass spectrometry (GC-MS) was used to analyze VCs in musk samples.
- Network pharmacology was employed to predict targets and pathways related to stroke.
- Molecular docking was performed to validate interactions between VCs and identified targets.
Main Results:
- 99 VCs were identified, with muscone, phenol, acetic acid, and isovaleric acid being prominent.
- Differences in organic acids and ketones distinguished white musk from other varieties.
- Network pharmacology identified 180 potential stroke-related targets, highlighting SRC, EGFR, ESR1, PTGS2, and DRD2 as key targets.
- Molecular docking confirmed binding affinity between major VCs and key targets.
Conclusions:
- Distinct volatile compositions exist among different musk types.
- Musk VCs, particularly muscone and phenol, show significant potential for stroke treatment.
- The identified targets and pathways provide a basis for understanding musk's therapeutic mechanisms in neurological disorders.
More Related Videos
Related Concept Videos
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...

